JCEM:25(OH)D水平或可反应心血管疾病风险

2013-10-21 desperado-c dxy

多项研究提示低血清25–羟维生素D[25(OH)D]浓度与高心血管疾病(CVD)风险有关,但这方面的证据仍不确定,多数证据基于CVD死亡率,且研究中的25(OH)D测量方法单一。为在同一的研究人群中通过重复测量25(OH)D并分析竞争风险,以评估25(OH)D与致命性和非致命性CVD的关系,来自德国癌症研究中心的Laura Perna教授及其团队进行了一项研究,发现低25(OH)D水平与CVD风险


血清25羟维生素D水平与心血管疾病、冠心病和中风的关系

多项研究提示低血清25–羟维生素D[25(OH)D]浓度与高心血管疾病(CVD)风险有关,但这方面的证据仍不确定,多数证据基于CVD死亡率,且研究中的25(OH)D测量方法单一。为在同一的研究人群中通过重复测量25(OH)D并分析竞争风险,以评估25(OH)D与致命性和非致命性CVD的关系,来自德国癌症研究中心的Laura Perna教授及其团队进行了一项研究,发现低25(OH)D水平与CVD风险中度增加相关。该研究结果在线发表于2013年10月8日的The Journal of Clinical Endocrinology & Metabolism杂志上。【原文下载】

该研究为一项以人群为基础的队列研究(ESTHER研究,基线2000-2002年),分别于基线后2年、5年和8年收集随访数据,生存者响应率为99.9%。研究受试者由他们的全科医师在健康普查过程中招募。在基线和随访5年后收集血液标本测量25(OH)D。共9949例男女受试者纳入该研究,基线年龄50-74岁,均有足够的德语知识并居住在德国萨尔州。主要评价指标包括总的心血管疾病、冠心病(CHD)和中风事件,并区分致命性和非致命性事件。

该研究结果发现,总体来说,8年随访期间,854例受试者发生非致命性CVD事件,176例受试者发生致命性CVD事件。在校正了重要的潜在混杂因素的模型中,25(OH)D水平低于30nmol/l的受试者与25(OH)D水平高于50nmol/l受试者相比,总CVD风险比为1.27,致命性CVD风险比为1.62。非致命性CVD与25(OH)D水平之间没有观察到明显的相关性。在剂量-反应分析中,观察到在25(OH)D水平低于75nmol/l时,心血管风险增加。CHD和中风的结果与CVD综合结果相似。

该研究结果表明,25(OH)D水平低与CVD风险中度增加有关,并且致命性CVD事件与25(OH)D的相关性显著强于非致命性CVD事件。

原文检索:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2062829, encodeId=796c2062829b3, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Wed Feb 12 07:40:00 CST 2014, time=2014-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777448, encodeId=87971e77448c9, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu May 29 23:40:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472934, encodeId=323114e29341d, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Wed Oct 23 02:40:00 CST 2013, time=2013-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497805, encodeId=f47a149e80535, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Oct 23 02:40:00 CST 2013, time=2013-10-23, status=1, ipAttribution=)]
    2014-02-12 achengzhao
  2. [GetPortalCommentsPageByObjectIdResponse(id=2062829, encodeId=796c2062829b3, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Wed Feb 12 07:40:00 CST 2014, time=2014-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777448, encodeId=87971e77448c9, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu May 29 23:40:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472934, encodeId=323114e29341d, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Wed Oct 23 02:40:00 CST 2013, time=2013-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497805, encodeId=f47a149e80535, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Oct 23 02:40:00 CST 2013, time=2013-10-23, status=1, ipAttribution=)]
    2014-05-29 smallant2015
  3. [GetPortalCommentsPageByObjectIdResponse(id=2062829, encodeId=796c2062829b3, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Wed Feb 12 07:40:00 CST 2014, time=2014-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777448, encodeId=87971e77448c9, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu May 29 23:40:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472934, encodeId=323114e29341d, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Wed Oct 23 02:40:00 CST 2013, time=2013-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497805, encodeId=f47a149e80535, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Oct 23 02:40:00 CST 2013, time=2013-10-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2062829, encodeId=796c2062829b3, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Wed Feb 12 07:40:00 CST 2014, time=2014-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777448, encodeId=87971e77448c9, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Thu May 29 23:40:00 CST 2014, time=2014-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472934, encodeId=323114e29341d, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Wed Oct 23 02:40:00 CST 2013, time=2013-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497805, encodeId=f47a149e80535, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Oct 23 02:40:00 CST 2013, time=2013-10-23, status=1, ipAttribution=)]